Venture Capital interview preparation
Sourcing, unit economics, term sheets, cap tables, fund economics and the India venture market. Every question is either traced to a named firm from a public candidate report, or tagged at desk level when we could not trace it — answers lead with the point, then the mechanism, then the limitation.
100 questions, mapped to the firms that asked them
- Questions
- 100
- Traced to a firm
- 31
- Firms
- 12
- Updated
- September 2026
061How do you think about signalling risk from a multi-stage fund?Early-stage VCSeed funds
Say this
If a fund with a large Series A vehicle writes your seed cheque and then declines to lead your A, the market reads it as inside information that the company is not working. The seed capital comes with an option the fund holds and the founder pays for.
Then walk it
- The mechanism: an incoming Series A investor asks why the seed fund with $2bn under management and an obvious ability to lead is not leading. There is rarely a good answer, and the absence of one prices the round or kills it.
- Why it is asymmetric: the multi-stage fund gets a cheap look at fifty companies and a free option on the best few. The founder gets capital plus a hidden liability that only appears at the next raise, precisely when they have no leverage.
- How founders manage it: take the multi-stage seed cheque as a small, non-lead participation alongside a dedicated seed fund that has no Series A vehicle, so there is no inference to draw. Or get an explicit, written commitment about what the fund will do at the A — which is worth less than it sounds but does change the conversation.
- How the fund should manage it, and this is the answer they want from someone joining one: be explicit at the time of the seed investment about whether this is a scout-style option or a genuine seed position, and if you do not lead the A, say why publicly and warmly to the incoming investors. Silence is what does the damage.
- The counterargument is real too: multi-stage money at seed is cheaper and comes with more resource, and many founders would rather have it. Signalling risk is a cost, not a disqualifier, and founders who price it correctly still often take the money.
- And the honest asymmetry from the fund's side: the signal cuts the other way as well. When a top multi-stage fund does lead the A, the round prices higher and fills faster than it would otherwise. Founders are buying a positive signal along with the negative option.
Where candidates lose it
Describing signalling risk as a founder problem only. In an interview at a multi-stage firm, the useful answer says how the firm should behave to reduce it, because that is a live internal debate at every one of them. And do not present it as a reason multi-stage seed money is bad — it is a cost to be priced.
Expect next
- How would you reduce it if you ran the seed programme here?
- Would you rather have a dedicated seed fund or a multi-stage fund lead your seed?
- What does it mean when a seed fund does not take its pro rata?
062What does a venture investor actually do on a board?Growth equityIndian venture capital
Say this
Three real jobs: hire and if necessary replace the CEO, approve the things that cannot be undone, and make sure the company does not run out of money by accident. Everything else — advice, introductions, recruiting help — is valuable but is not a board function, and confusing the two is how directors overstep.
Then walk it
- The fiduciary duty runs to the company and all shareholders, not to the fund that appointed you. That distinction matters in practice, because the moment a sale price is being negotiated your fund's preference and the common's interests diverge, and a director who behaves as the fund's agent creates real legal exposure.
- The formal work: approve the budget, approve financings and option grants, approve a sale, and set CEO compensation. Roughly six meetings a year, plus a lot of between-meeting contact that is where the actual influence sits.
- The single most important decision a venture board makes is whether the CEO is the right CEO for the next stage. It is rare, it is painful, and boards are systematically too slow at it — the modal error is eighteen months of hoping.
- The cash-watch job: knowing the runway to the month, forcing the conversation about the next raise nine months before the cash runs out rather than three, and being honest about whether the fund will support a bridge. A board that lets a company drift into a two-month cash position has failed.
- Then the non-board value-add, which is most of what a founder actually wants: candidate introductions, customer introductions, pricing and go-to-market pattern recognition, and being the person the CEO can say 'I am out of my depth' to. That last one requires you to have never punished honesty in a board meeting.
- The discipline to state: the board does not run the company. A director who starts directing functional decisions destroys the CEO's authority with their own team, and the good ones ask questions in the meeting and give opinions outside it.
Where candidates lose it
Answering with the value-add list — introductions, advice, coaching — and never naming the fiduciary role or the CEO decision. Those are the board's actual powers. And missing that your duty is to all shareholders rather than to your fund, which is the question behind most board-conflict scenarios.
Expect next
- What happens when your fund's interests and the common shareholders' diverge?
- How would you handle a CEO who needs replacing?
- What is the difference between a board seat and an observer seat?
063You are on the board and the CEO wants to fire their co-founder. What do you do?Early-stage VCGrowth equity
Say this
Slow it down by two weeks, get the facts independently, then support a clean decision either way. My job is not to adjudicate the relationship — it is to make sure whichever way it goes, the company keeps functioning and the equity consequences are handled properly before anyone is told.
Then walk it
- First, separate the question of whether the person should go from the question of how. The first is a performance judgement I should test; the second is where boards do the real damage by rushing.
- Get independent information. Talk to the co-founder directly, talk to two or three people who work with both of them, and understand whether this is a capability gap, a role that has outgrown the person, or a personal breakdown. Those three have different answers — the second is often solved by changing the role rather than removing the person.
- Then the equity question, before any conversation happens. What is vested, what accelerates, what does the shareholders' agreement say about a departing founder's shares, and is there a repurchase right. A founder leaving with 18 percent fully vested and no involvement is a problem every future investor will raise, and the time to negotiate it is before the termination, not after.
- Then the operational question: what does this person actually hold? Key customer relationships, the entire backend, the regulatory licence in their name. I have seen a co-founder removal take out a third of engineering because nobody mapped the dependency first.
- Then support the CEO if the case holds. A board that blocks a CEO's decision about their own leadership team, without a serious reason, has just told the CEO they are not in charge. But I would also say clearly that this is a signal about the CEO — how they handle it, whether they are generous, and whether they have been avoiding the conversation for a year.
- And be honest about the pattern: the modal error here is not firing too fast, it is a board that let a broken co-founder relationship run for eighteen months because nobody wanted the conversation. Speed in the decision, care in the execution.
Where candidates lose it
Taking sides immediately, in either direction. Backing the CEO reflexively ignores your duty to all shareholders and to the facts; blocking them undermines their authority. The structure is: pause, verify independently, sort the equity and dependency consequences first, then support a clean decision.
Expect next
- What if the departing founder has 20 percent fully vested?
- What if you think the CEO is the problem, not the co-founder?
- How do you handle the announcement to the team and to customers?
064What should the board look like at Series A, and what changes by Series C?Growth equity
Say this
At Series A, five seats: two founders, the Series A lead, the seed investor or a second common seat, and one genuinely independent director. By Series C it grows to seven with more investor and independent seats, and the founders no longer control it — which is the real change.
Then walk it
- The standard Series A structure is two common, one preferred, and two independents agreed by both sides, or the simpler three-two split with founders holding the majority. Either way the founders still effectively control the board at the A, and that is normal and healthy.
- The independent seat is the one most people undervalue. It is the tie-breaker, and if you pick someone with genuine operating experience at the next stage of scale, they contribute more than any investor director does. The mistake is leaving it empty for two years, which happens constantly.
- By Series B and C, each new lead wants a seat and the board drifts to seven or nine. At some point the investor plus independent seats outnumber the founders, and control has shifted. Founders often do not register the moment it happens because it arrives one seat at a time.
- So the counter-discipline: cap the board at seven, move later investors to observer status rather than full seats, and add independents rather than investors as the company scales. A nine-person venture board does not make better decisions, it makes slower ones and pushes the real conversations into side calls.
- What also changes by Series C is the work. An A board is about product-market fit, hiring and the next raise. A C board is about operating discipline, the finance function, audit and compensation committees, and starting to think about what a public company or an acquisition needs.
- And a governance detail worth knowing: founders preserve control through mechanisms other than board seats — super-voting shares, or a voting agreement that ties specific seats to whoever holds the founder shares. Board composition and voting control are separate levers and sophisticated founders manage both.
Where candidates lose it
Describing a board as just a headcount. The substance is who controls it, when control shifts, and that independents are more valuable than extra investor seats. Also failing to distinguish board control from voting control — they are separate and founders often keep one while losing the other.
Expect next
- At what point do the founders lose board control, and does it matter?
- How would you choose an independent director?
- Would you take an observer seat instead of a board seat?
065In diligence you find that a founder overstated revenue. What do you do?Growth equity
Say this
Establish whether it was a definitional error or a deliberate misstatement, in that order, because they lead to completely different outcomes. A founder counting signed letters of intent as ARR is a founder who needs better accounting. A founder who knowingly gave me a number they knew was false is a pass, regardless of how good the company is.
Then walk it
- First, go back to the primary data. Pull the bank statements, the invoices, the contracts and the accounting system, and rebuild the revenue figure myself. Do not go to the founder with an accusation built on a spreadsheet inconsistency.
- Then classify it. Definitional: counting bookings as revenue, annualising a one-month pilot, including a non-binding LOI, or recognising a multi-year contract upfront. All of these are common, mostly honest, and mostly fixable with a CFO.
- Deliberate: a number the founder knew was wrong, presented to raise money. That is a character finding and it is disqualifying. The reason is not moralism — it is that I am buying an illiquid position for eight years in a company where the only source of information is this person's word.
- Ask the question directly and watch the response. The good outcome sounds like 'you're right, we've been counting it as bookings and I should have flagged it'. The bad outcome is a moving explanation, or blaming the analyst, or a number that changes again when pressed.
- Then check whether it is systemic. If revenue was overstated, look at retention, pipeline and headcount too. One inflated metric is rarely alone, and a pattern converts a definitional problem into a deliberate one.
- And the obligation to others: if I pass on a character finding, I would tell my own partnership plainly why. Whether to tell other investors is genuinely harder — there is defamation risk and I would take legal advice — but I would not give a positive reference, and I would say nothing rather than something misleading.
Where candidates lose it
Jumping straight to 'I'd walk away'. It sounds principled and it shows no judgement, because most revenue discrepancies at seed and Series A are definitional. The structure is: verify from primary documents, classify honest versus deliberate, test with a direct question, then act. Only the deliberate case is an automatic pass.
Expect next
- Where is the line between aggressive and dishonest?
- Would you tell other investors?
- What if you had already signed the term sheet?
066How would you structure a bridge round for a portfolio company that is six months from running out of cash?Early-stage VCGrowth equity
Say this
First establish what the bridge is bridging to — a specific metric that makes the next round fundable, not just more time. Then size it to reach that milestone with three months of buffer, structure it as a convertible instrument inside the existing syndicate, and make the cut in costs a condition rather than a suggestion.
Then walk it
- The diagnostic question first: is this a bridge or a pier? A bridge reaches a specific, credible milestone — $4m of ARR, a signed enterprise customer, a clinical result. A pier is money that buys time with no defined destination, and it is the most common way funds throw good capital after bad.
- Size it properly. Six months of runway is usually not enough to hit anything, so size to twelve to fifteen months including a cut, and be honest that a small bridge just brings you back to the same conversation with less credibility.
- Structure: typically a convertible note or SAFE that converts into the next priced round at a discount, often 15 to 25 percent, sometimes with a cap set near the last round. This avoids setting a new price at the worst possible moment, which is the main reason bridges are done as convertibles rather than priced rounds.
- Who funds it: the existing syndicate, pro rata. An inside round at a discount is normal. The decision is whether every existing investor participates — if one refuses, the others are effectively subsidising them, which is when pay-to-play or a senior preference for the bridge money gets negotiated.
- Conditions, and this is where the real work is. A cost reduction that extends the runway on its own, a revised plan the board signs off on, and usually a commitment about the fundraising process starting by a specific date. Bridge capital without operational conditions attached is a gift, not an investment.
- And the honest internal test: would I put this money into a new company at the implied price instead? If not, I should consider whether the right answer is a smaller bridge aimed at a sale of the company rather than at another round. Funding a managed exit is a legitimate and underused use of bridge capital.
Where candidates lose it
Structuring the instrument before establishing what the milestone is. The financial engineering is the easy part; the judgement is whether there is a credible destination. And never propose a bridge without a cost cut attached — every experienced investor will ask, and 'we didn't want to demoralise the team' is not an answer.
Expect next
- What if one existing investor refuses to participate?
- When is the right answer to fund a sale instead of a bridge?
- Would you set a cap on the bridge, and where?
067Walk me through a down round and what it does to the cap table.Growth equityLate-stage VC
Say this
New money comes in at a lower price per share than the last round, so the dilution is severe, anti-dilution provisions fire and reprice earlier preferred, and the option pool is usually underwater so it has to be refreshed. The founders and employees absorb almost all of it.
Then walk it
- Start with the raw dilution. A company that raised at $200m post now raising $30m at $80m post gives the new money 37.5 percent, so everyone else is diluted by well over a third in one round.
- Then anti-dilution fires. Earlier preferred with weighted-average protection gets a lower conversion price and therefore more shares, and that adjustment comes entirely out of the common. With a full ratchet anywhere in the stack, the effect is brutal — earlier investors can end up with multiples of their original share count.
- Then the option pool problem, which people forget. Employee options struck at the old, higher price are worthless, so retention has collapsed. The fix is a new pool at the new strike, sometimes plus a repricing or exchange of existing grants, and that is another 10 to 15 percent of dilution on top.
- Put it together and a founding team at 35 percent before a serious down round can be in the low teens after it, with the option pool refreshed and the preference stack still sitting above them. The practical consequence is that the equity no longer motivates anyone, which is why down rounds are followed by departures.
- So the conversation the board has to have is about restructuring, not just pricing: converting some of the old preference stack to common, cutting the aggregate preference back, and issuing meaningful new founder and management grants. A clean down round with a reset stack is far better than a high-priced round loaded with structure.
- And the signalling and legal points. A down round is a repricing of the story as well as the shares, so customers and candidates hear about it. And existing directors approving a round in which their own funds participate at a favourable price sit in an obvious conflict, which is why an independent committee or a fairness process matters more here than anywhere else.
Where candidates lose it
Only calculating the arithmetic dilution and stopping. The full answer has four layers: raw dilution, anti-dilution firing, the underwater option pool, and the resulting retention problem. Missing the option repricing is the most common gap, and it is the one that actually determines whether the company survives the round.
Expect next
- Would you rather do a clean down round or a flat round with 3x participating preferred?
- How do you handle underwater employee options?
- What is the conflict when existing investors lead the round?
068Why is a structured round often worse for a company than a clean down round?Late-stage VCGrowth equity
Say this
Because it preserves the headline valuation by burying the real price in terms nobody outside the deal can see. The company looks like it raised flat, but a 2x senior participating preference with a full ratchet means the common is worth far less than in an honest down round at a lower price.
Then walk it
- What structure means in practice: multiple liquidation preference, participation, senior rather than pari passu ranking, full ratchet anti-dilution, guaranteed IPO returns or ratchets on the IPO price. Each one transfers value from common to the new preferred without touching the headline number.
- Run it. A flat $500m round with $150m of new money at 2x senior participating means the first $300m of any exit goes to the new investor before anyone else sees a rupee. At a $400m exit, the common gets almost nothing — worse than if the round had simply priced at $200m with clean terms.
- The second cost is compounding: structure is senior and it stacks. The next investor demands terms at least as good, so you get a tower of preferences, and by the third round the common is a call option struck impossibly high. Employees work out that their options are worthless well before the board admits it.
- The third cost is optionality on exit. A heavy preference stack means a $300m sale pays management nothing, so the team will not sell, so the company keeps raising. Structure removes the reasonable exits and forces an all-or-nothing outcome.
- The clean alternative: reset the price, take the dilution, refresh the option pool, and keep the stack at 1x non-participating. Everyone knows where they stand, the recruiting story is honest, and a mid-sized exit still pays the team.
- This was the defining mistake of the 2021 to 2022 period. A lot of companies protected a unicorn headline with structure and discovered two years later that the structure, not the valuation, was what made them unfinanceable and unsellable. Being able to say that with a specific example is what makes this answer land.
Where candidates lose it
Treating a flat round as good news. Any time a valuation holds in a bad market, the first question is what the terms were. A candidate who does not ask for the preference stack before commenting on a valuation has not understood how late-stage rounds are actually priced.
Expect next
- What is an IPO ratchet and who does it hurt?
- How would you find out whether a reported valuation was structured?
- As the founder, which would you choose and why?
069Would you sell a position in the secondary market, and how is secondary priced?SecondariesGrowth equity
Say this
Yes, in three situations: the position has grown so large it dominates the fund, the fund is at the end of its life and needs to return capital, or my view has changed but the company is still marked up. Pricing is typically a discount to the last round, with the discount reflecting information asymmetry and the buyer's lack of rights.
Then walk it
- Pricing mechanics: secondary trades reference the last primary round price, then discount it. Direct secondaries in strong companies can trade near or above the last round; ordinary positions in reasonable companies trade at 20 to 40 percent discounts; and in a weak market or a company that has not raised for two years, discounts of 50 to 70 percent are normal.
- What drives the discount: how stale the last round is, whether the buyer gets information rights or is buying blind, whether the shares are common or preferred, and transfer restrictions — most private companies have rights of first refusal and board consent on transfers, which alone knocks off value.
- Why a fund sells. First, concentration: a position at 40 percent of fund NAV is a risk-management problem regardless of conviction. Second, fund life — a ten-year fund in year eleven has LPs who want cash, and DPI is the number they judge you on. Third, a changed view while the mark is still good.
- The other side of it, which is the more interesting answer in an interview: buying secondary. Late-stage secondary is where a lot of the best risk-adjusted venture returns have sat since 2022, because you can buy a company with real revenue at a large discount to a price that was set in a completely different market. The diligence problem is that you may get no access to the company.
- Then the structures: direct secondary from an early investor or employee, an LP-interest sale of a whole fund stake, a continuation vehicle where the GP moves assets into a new fund with new capital, or a strip sale of several positions. Each has different pricing and different conflicts.
- And the conflict I would name: a GP selling to a continuation fund they also manage is on both sides of the trade. That requires an independent valuation and an LP advisory committee sign-off, and it is the governance issue LPs currently care most about.
Where candidates lose it
Treating secondary as a distressed-only market. Since 2022 it has been a core part of how venture liquidity works, and employee tender offers and continuation vehicles are routine. Also quoting a discount without naming what drives it — staleness, rights, and transfer restrictions are the three levers.
Expect next
- How would you diligence a secondary position with no access to the company?
- What is a continuation vehicle and what is the conflict?
- Would you buy or sell in today's market?
070M&A or IPO — which exit do you push for?Growth equity
Say this
Whichever produces more risk-adjusted cash for the fund, and for the overwhelming majority of venture-backed companies that is M&A, because the bar for a good IPO is much higher than people assume. IPO is right for a small number of companies with genuine scale, predictability and a reason to be public.
Then walk it
- The numbers frame it: the large majority of venture exits are trade sales, and only a small fraction of venture-backed companies ever list. Pushing for an IPO on a company that is not ready is how a $600m acquisition offer gets turned down and becomes a $200m sale two years later.
- What an IPO actually needs today: roughly $200m-plus of revenue, predictable growth in the 25 to 30 percent range, a path to profitability on a defined timeline, clean accounting, a public-company finance function, and a CEO who wants the job. Any one of those missing and the listing is a bad idea even if a bank says otherwise.
- M&A advantages: certainty, speed, cash at close, no lockup, and often a strategic premium a public market will not pay because the acquirer values synergy. For the fund, cash at close is DPI, and DPI is what LPs judge you on.
- IPO advantages: no ceiling on the outcome, so the genuinely great companies are worth far more public than any acquirer would pay. Plus the ability to keep compounding — a fund holding a position post-IPO through a lockup has sometimes made more in the two years after listing than in the eight before it.
- The practical conflict I would name: the fund may want liquidity before the founder does, or the reverse. A partial secondary at the last round, or selling into a strategic round, resolves more of these tensions than people expect and is worth raising before the exit conversation becomes adversarial.
- And the India-specific version, because it is now genuinely different: the domestic listing market has become a real exit route rather than a theoretical one, with a run of consumer internet and fintech listings absorbing large amounts of venture stock. For an India-focused fund the IPO path is more available than it was five years ago, and that has changed how those funds model exits.
Where candidates lose it
Defaulting to IPO as the prestige outcome. Interviewers are testing commercial judgement, and the judgement is that M&A is the base case for almost everything. Give the concrete readiness bar for an IPO — revenue scale, predictability, profitability path — because a candidate who cannot name it is guessing.
Expect next
- What revenue scale does a company need to list today?
- How do you handle a lockup as a fund?
- Has the Indian listing market changed the calculus for India-focused funds?
Firm tags come from public, anonymous candidate reports on Wall Street Oasis: strong signal, not sworn testimony. Firms are named as the places a question was reported, not as partners of Fin Maverick. Answers are written for this page to show how to think out loud; they are not scripts to recite.
